US FDA advisers back Replimune skin cancer drug trial data - Reuters
US FDA advisers back Replimune skin cancer drug trial data Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPaWRkMjZ0enVTN1Y5ZzlPRjlMUUFCbWZjUmpvb0VILXZKaTdid2hHbVl2NGl5N3FXNlZrNGF6UXpjaFM0Vk5ZUUp6ejZ0Sm14NXNvWmZBd1A1RXVoQVJqc01XNDdGX0h0LWpRMXNhUUoxRmNGemRCZUVQcFZvYXZ4UU5CYlc5dkVtZHlnZ3JjNDYtSnMtSmY2ZUhYZXRpamx6XzZDblpIOTVxdjlETmxncGVxVG5FcFF4LUhXXzhNRHhVNmdyY3pR?oc=5" target="_blank">US FDA advisers back Replimune skin cancer drug trial data</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMUS FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMUS FDA flags four deaths in Newron's schizophrenia drug studies - Reuters
US FDA flags four deaths in Newron's schizophrenia drug studies Reuters
October 8, 2026 at 05:47 PMUS appeals court weighs block on Kennedy's vaccine panel appointments - Reuters
US appeals court weighs block on Kennedy's vaccine panel appointments Reuters
October 6, 2026 at 06:41 PMHalozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PMUS health secretary Kennedy launches new push on vaccine injuries - Reuters
US health secretary Kennedy launches new push on vaccine injuries Reuters
October 8, 2026 at 09:59 PM